ICON Reports Fourth Quarter and Full Year 2023 Results
Full year net business wins of $9,946 million; a net book to bill of 1.22.
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
ICON announces that it will release its financial results for the fourth quarter and full year 2023 results after the market closes on Wednesday, February 21, 2024.
New ICON survey highlights importance of combination therapies in future obesity treatment
ICON announced results from a recent industry survey of over 100 professionals engaged in obesity-related clinical research to measure industry opinions on trends within this therapeutic area.
ICON Issues Financial Guidance for Full Year 2024
ICON plc today announced its financial guidance for the year ending December 31, 2024.
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
ICON plc today launched its “Optimising biotech funding” whitepaper. This provides an overview of the current state of play for biotech companies and the research and development (R&D) strategies they can adopt to attract and best utilise investment funding.
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ICON plc today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 5:15pm PST/8.15pm EST.
ICON wins industry accolades from TIME Magazine, Forbes and Financial Times in second half of 2023
ICON plc finishes the second half of 2023 with positive recognition as a top-rated employer and leader in clinical trial innovation.
ICON secures upgraded credit rating from Moody’s Investors Service
Moody's Investors Service ("Moody's") upgraded all of ICON plc’s instrument ratings to Baa3 with a stable outlook. This reflects the stronger credit profile of the ICON Group, which Moody’s now views as comparable in aggregate to Baa3 peers.
ICON plc to Present at Upcoming Investor Conferences
ICON plc today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the Jefferies London Healthcare Conference on Tuesday, November 14, 2023 at 2:00pm GMT. Mr. Brendan Brennan will also present at the Evercore HealthCONx Conference on Wednesday, November 29, 2023, at 12:30pm ET.
ICON Reports Third Quarter 2023 Results
Quarter three revenue of $2,055.1 million representing an increase of 5.8% on prior year revenue.